VSTM Shares Outstanding History
Below is a table of the VSTM shares outstanding history going back to 1/27/2012:

Date VSTM Shares Outstanding
1/27/201219.23M
3/15/201221.06M
5/4/201221.06M
8/10/201221.25M
11/9/201221.26M
2/28/201321.15M
4/30/201321.29M
7/31/201325.59M
11/7/201325.65M
2/28/201425.82M
4/30/201425.83M
7/31/201425.84M
10/23/201425.89M
2/27/201535.96M
5/6/201536.54M
8/5/201536.90M
10/29/201536.93M
2/22/201636.99M
5/2/201636.99M
8/2/201636.99M
10/31/201636.99M
3/15/201736.99M
5/8/201736.99M
8/4/201736.99M
11/6/201740.49M
3/7/201850.80M
8/6/201873.59M
11/2/201873.74M
3/7/201973.87M
5/2/201973.88M
8/1/201974.14M
10/30/201974.35M
3/11/2020148.41M
5/6/2020162.53M
8/7/2020169.53M
11/6/2020169.77M
3/17/2021171.67M
5/10/2021171.92M

Also see: VSTM Market Cap History
VSTM YTD Return
VSTM Historical Shares Outstanding:
+26.60% CAGR
VSTM Historical Shares Outstanding: +26.60% CAGR

Mouse over chart for data details
1/27/2012 ...5/10/2021
Verastem is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and life of cancer patients. Co.'s marketed product, COPIKTRA® (duvelisib) capsules, and primary product candidates, defactinib and CH5126766, utilize a multi-faceted approach designed to treat cancers originating either in the blood or major organ systems. Co. is developing duvelisib and its product candidates in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, colorectal cancer and pancreatic cancer. Co. is also developing duvelisib for the treatment of patients with peripheral T-cell lymphoma. We show 38 historical shares outstanding datapoints in our coverage of VSTM's shares outstanding history.

Understanding the changing numbers of VSTM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VSTM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VSTM by allowing them to research VSTM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for VSTM:
VSTM SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Verastem (VSTM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VTGN Shares Outstanding History
VTL Shares Outstanding History
VTVT Shares Outstanding History
VVUS Shares Outstanding History
VYGR Shares Outstanding History
WAT Shares Outstanding History
WCG Shares Outstanding History
WINT Shares Outstanding History
WMGI Shares Outstanding History
WOOF Shares Outstanding History
More Healthcare companies »

 

VSTM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.